Intech Investment Management »

BioCryst Pharmaceuticals shares owned by Intech Investment Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Intech Investment Management from 13F filings

Historical chart of Intech Investment Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Intech Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Intech Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $412k 54k 7.60

More positions owned by Intech Investment Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
UnitedHealth (UNH)
Progressive Corporation (PGR)
Chipotle Mexican Grill (CMG)
Wal-Mart Stores (WMT)
Constellation Energy (CEG)
Netflix (NFLX)
Hca Holdings (HCA)

View all positions for Intech Investment Management

Top funds holding BioCryst Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group
T. Rowe Price Associates

View all funds holding BioCryst Pharmaceuticals